- Home
- ANGO vs GBLI Comparison
ANGO vs GBLI Comparison
Compare ANGO & GBLI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ANGO | GBLI |
|---|---|---|
| Founded | 1988 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Property-Casualty Insurers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 420.2M | 444.5M |
| IPO Year | 2004 | 2010 |
Fundamental Metrics
Financial Performance| Metric | ANGO | GBLI |
|---|---|---|
| Price | $15.49 | $25.00 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $18.00 | N/A |
| AVG Volume (30 Days) | ★ 367.1K | 5.7K |
| Earning Date | 04-02-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 5.13% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 1.05 |
| Revenue | $291,010,000.00 | ★ $450,098,000.00 |
| Revenue This Year | $9.51 | $14.23 |
| Revenue Next Year | $4.96 | $9.68 |
| P/E Ratio | ★ N/A | $23.84 |
| Revenue Growth | ★ 10.17 | 2.02 |
| 52 Week Low | $9.39 | $23.97 |
| 52 Week High | $16.29 | $30.50 |
Technical Indicators
Market Signals| Indicator | ANGO | GBLI |
|---|---|---|
| Relative Strength Index (RSI) | 51.94 | 35.45 |
| Support Level | $14.91 | N/A |
| Resistance Level | $16.15 | $29.24 |
| Average True Range (ATR) | 0.47 | 1.43 |
| MACD | -0.04 | -0.57 |
| Stochastic Oscillator | 56.85 | 10.42 |
Price Performance
Historical ComparisonAbout ANGO AngioDynamics Inc.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.
About GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC is a United States-based holding company with a diversified portfolio of property and casualty insurance-related entities. Along with its subsidiaries, the company operates in the following reportable segments: Agency and Insurance Services, Belmont Insurance Companies - Core (Belmont Core), and Belmont Insurance Companies - Non-Core (Belmont Non-Core). Maximum revenue is generated from the Belmont Core segment, which offers direct insurance and assumed reinsurance products in the E&S (Excess and Surplus) marketplace. The Agency and Insurance Services segment is focused on sourcing, underwriting, and servicing primary and assumed reinsurance business; and specialized insurance service businesses providing technology, AI-enabled marketplace, and claims services.